Full Professor(heuristic)

Advanced Breast Cancer Therapies · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index90
i10-index319
Publications1,145
Citations39,546

Grants

1 total · 1 active

NIH #R01CA260890

Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer

Active
Amount
$500K–$600K
Period
2022-01-01 → 2026-12-31
PIs
2

Awarded at MASSACHUSETTS GENERAL HOSPITAL

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

1 total · 1 active

NIH #R01CA260890

Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer

Active
Amount
$500K–$600K
Period
2022-01-01 → 2026-12-31
PIs
2

Awarded at MASSACHUSETTS GENERAL HOSPITAL

Recent Public Signals

  1. New paper: Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer (npj Breast Cancer)2026-07-01
  2. New NIH award: Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer2022-01-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-4885-1157

Professor Insights

Career Trajectory